Status:
UNKNOWN
Comparison of Cefdinir and Cefdinir/Clavulanic Acid Combination in Adults
Lead Sponsor:
Neutec Ar-Ge San ve Tic A.Ş
Conditions:
Acute Exacerbation of Chronic Bronchitis
Community-Acquired Pneumoniae
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
It is planned to compare the efficacy and safety of cefdinir and cefdinir/clavulanic acide treatments in acute exacerbation of chronic bronchitis (AECB) and community-acquired pneumoniae (CAP) patient...
Eligibility Criteria
Inclusion
- The diagnosis of chronic bronchitis
- The diagnosis of community-acquired pneumoniae
- FEV1 value = 30-80%
- The diagnosis of mild-severe acute exacerbation of chronic bronchitis (AECB)
- Oxygen saturation \< 90%
Exclusion
- Pregnancy or breastfeeding
- Allergy against to penicillin or cephalosporins
- Renal impairment
- Active hepatic disease
- Antibiotic use except study drugs
- Immunosuppressive therapy before 6 months of study initiation
- Use of probenecid like drugs
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03400735
Start Date
November 1 2017
End Date
August 1 2018
Last Update
January 17 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Erzincan University Mengücek Gazi Training and Research Hospital
Erzincan, Turkey (Türkiye)
2
Yedikule Chest Diseases Training and Research Hospital
Istanbul, Turkey (Türkiye)